http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306858-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
filingDate | 1998-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2001-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93d7805a3dcec0b3d18a02c05681e52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b8418576969a21653020222be3b791 |
publicationDate | 2001-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-6306858-B1 |
titleOfInvention | Zwitterionic fatty acid compounds for anti-inflammation |
abstract | Methods for treating muscular inflammation comprise applying to an inflamed area a therapeutically effective amount of a skin-compatible ester of a zwitterionic aminosulphonic acid of the formulawherein M is an alkali metal and R is a straight chain aliphatic acid moiety. Compositions for treating inflammation comprising a therapeutically effective amount of a skin-compatible component comprising an ester, ether, urethane, amide or urea of at least one compound selected from a specified group. Additional methods for treating inflammation comprise applying to an inflamed area a therapeutically effective amount of a skin-compatible component comprising an ester, ether, urethane, amide or urea of at least one compound selected from a specified group. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100393214-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100361578-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100361579-C |
priorityDate | 1997-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 261.